Search for: "Eli, Inc." Results 181 - 200 of 1,000
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Nov 2011, 7:21 am
In its second intellectual property appeal (the first being Lucasfilm v Ainsworth [2011] UKSC 39 see my case note "Lucasfilm v Ansoworth The Supreme Court's First IP Appeal" 31 July 2011 IP/IT Update) the United Kingdom Supreme Court had to consider the way in which the requirement of industrial applicability extends to a patent for biological material. [read post]
25 Oct 2020, 6:00 pm by Juvan Bonni
Daly, Crowley, Mofford & Durkee, LLP LSI Solutions Hanley, Flight & Zimmerman, LLC–Patent Associate Attorney Hanley, Flight & Zimmerman, LLC–Trademark Attorney Eli Lilly and Company–Patent Research Consultant Eli Lilly and Company–Patent Counsel Duane Morris LLP [read post]
21 Feb 2006, 10:13 pm
The consolidated defendants (Mylan Laboratories Inc, Mylan Pharmaceuticals, Inc., UDL Laboratories, Inc., Alphapharm Pty. [read post]
19 Aug 2010, 5:35 pm by Steve Bainbridge
The WSJ Law Blog excerpts this part of the opinion in American Atheists, Inc. v. [read post]
19 Dec 2017, 2:40 pm by Lawrence B. Ebert
TevaParenteral Medicines, Inc., 845 F.3d 1357 (Fed. [read post]
17 Jul 2011, 9:55 am by Hugh Tomlinson QC, Matrix Law
There are two appeals in the Supreme Court beginning with Human Genome Sciences Inc v Eli Lilly and Company to be heard on Monday 18 to Wednesday 20 July 2011 by Lords Hope, Walker, Neuberger, Collins and Clarke. [read post]
26 Apr 2007, 2:32 am
BusinessWeek notes another Congressional hearing on patent reform will occur on April 26, with testimony from Kevin Sharer, chief executive of biotech company Amgen Inc.; Anthony Peterman, patent counsel for computer manufacturer Dell Inc.; and Gary Griswold, president and chief counsel of intellectual property at 3M Co.Dell Inc. is a member of the Coalition for Patent Fairness, comprised mainly of IT companies strongly seeking patent reform (including Amazon.com, Apple,… [read post]
1 Jul 2010, 6:30 am by Peter Rost
Senator Charles Grassley asked 16 drugmakers, including Pfizer Inc., AstraZeneca Plc and Eli Lilly & Co., to reveal how they treat whistleblowers who file complaints under the False Claims Act.Grassley, an Iowa Republican, sent letters June 28 that posed eight questions such as how companies notify employees of the law, how they treat whistleblowers and what changes they have made in response to a 2009 law extending anti-retaliation protections. [read post]
9 Jun 2011, 12:43 pm by Jenna Greene
Covington & Burling lawyers yesterday scored a key win for Eli Lilly and Co. in a dispute over marketing a diabetes drug. [read post]
17 Feb 2010, 2:43 pm
This case concerns an appeal [2010] EWCA Civ. 33 from the August 2008 judgment in Eli Lilly & Co. v Human Genome Sciences Inc., [2008] EWHC 1903 (Pat), wherein Mr. [read post]
17 Feb 2010, 2:43 pm
This case concerns an appeal [2010] EWCA Civ. 33 from the August 2008 judgment in Eli Lilly & Co. v Human Genome Sciences Inc., [2008] EWHC 1903 (Pat), wherein Mr. [read post]